Latest News about mRNA
Recent news which mentions mRNA
Stocks Edge Up As Producer Inflation Supports Rate Cut Bets, Small Caps, Miners Rally: What's Driving Markets Thursday?
September 12, 2024
From Benzinga
Moderna Outlines Post-Covid Roadmap, Cuts Research Budget, Forecasts 2025 Sales Below Expectations
September 12, 2024
From Benzinga
Nasdaq, S&P 500 Set For Modest Gains As Investors Eye August Inflation Data And ECB Rate Decision
September 12, 2024
From Benzinga
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
September 12, 2024
From Motley Fool
GSK Halts Herpes Simplex Virus Vaccine Development, Clears Path For Other Contenders Like Moderna, BioNTech
September 11, 2024
From Benzinga
Is Hims & Hers Health the Next Teladoc?
September 11, 2024
From Motley Fool
Wall Street Rallies After Last Week's Sell-Off, Palantir Soars On S&P 500 Inclusion, Airlines Rally: What's Driving Markets Monday?
September 09, 2024
From Benzinga
Why Is Moderna Stock Trading Higher On Monday?
September 09, 2024
From Benzinga
Intel, Moderna And Dollar General Were Among Top 10 Large Cap Losers In August: Are The Others In Your Portfolio?
September 08, 2024
From Benzinga
Is It Time to Buy August's Worst-Performing Nasdaq Stocks?
September 07, 2024
From Motley Fool
Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows
September 06, 2024
From Benzinga
Jim Cramer: Oklo Is Losing Money 'Hand-Over-Fist,' But This Private Equity Stock Is A Buy
September 05, 2024
From Benzinga
Is It Time to Buy August's Worst-Performing S&P 500 Stocks?
September 04, 2024
From Motley Fool
UK, Taiwan Approve Moderna's Updated COVID-19 Shot
September 03, 2024
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 03, 2024
From Benzinga
Magnificent 7 Miss Out, 2 Cybersecurity Stocks Stand Firm, Retailers Lag In Volatile August: Here Are The Top S&P 500 Gainers And Losers
August 31, 2024
From Benzinga
Moderna And BioNTech Bet On Personalized Cancer Vaccines To Revive Fortunes After Dwindling COVID-19 Vaccine Sales
August 29, 2024
From Benzinga
From Benzinga
From Benzinga
Americans To Access COVID-19 Test Kits For Free As US Government Restarts Free At-Home Program
August 26, 2024
From Benzinga
Snowflake, JD.com And Temu Parent PDD Are Among Top 8 Large Cap Losers Last Week (Aug 18-Aug 24): Are The Others In Your Portfolio?
August 25, 2024
From Benzinga
From Benzinga
Europe Approves Moderna's RSV Vaccine For Adults 60 And Over
August 23, 2024
From Benzinga
Nasdaq 100 Slumps 1.6% As Traders Turn Cautious Ahead Of Powell's Jackson Hole Address
August 22, 2024
From Benzinga
FDA Approves Updated COVID Vaccines From Pfizer And Moderna, But Leaves Out Novavax's Shot
August 22, 2024
From Benzinga
Moderna's Options: A Look at What the Big Money is Thinking
August 21, 2024
Tickers
MRNA
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
